CareDx, Inc. ( CDNA) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDT Hello, everyone. Thank you for joining us and welcome to the CareDx Q2 2026 Earnings Call. [Operator Instructions] I will now hand ...
Q2 2026 Earnings Call July 31, 2026 10:00 AM EDTCompany ParticipantsSusan Gille - Manager of Investor RelationsLisa ...
Highl ights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% ...
Highlights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is en ...
AtriCure (NASDAQ:ATRC) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you ...
There is no better case study than what we are seeing here in Texas with the growth in Houston, effectively keeping rates essentially flat for over a decade. Indiana has not seen the level of growth ...
Earnings call SMPL's Q3 FY26 results exceeded internal expectations but continued to show significant year-over-year declines: net sales fell 6.3% to $357M, gross margin dropped 390 bps to 32.5%, and ...
24/7 Wall St. on MSN
Samsung just out-earned Apple and Nvidia, and the stock tanked 7%
Quick ReadSamsung out-earned both Nvidia and Apple on profit despite a 6% consensus beat, then fell 7% because fast-money whisper targets were far higher.Micron surged 11% after a blowout quarter in ...
Objectives and expected results for the Canada Cultural Investment Fund The Canada Cultural Investment Fund (CCIF) encourages private sector investment, partnership, and sound business practices to ...
Reflects a pre-tax gain, net of transaction costs, recognized on the sale of Neurocrine Group Limited in January 2026. Estimated income tax effect of Non-GAAP reconciling items are calculated using ...
Delivered Q2 2026 revenue of $103.5 millionQ2 2026 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 32% over Q2 2025Raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results